Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02994719 · ClinicalTrials.gov registry record
Gait Analysis in Neurological Disease
A clinical trial of Parkinson's Disease and Huntington Disease, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT02994719 is a study of Parkinson's Disease and Huntington Disease that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 120 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02994719, a study of Parkinson's Disease and Huntington Disease, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate whether speed-dependent measures of gait can be identified in patients with neurological conditions that affect gait, particularly in subjects with parkinsonian disorders.
Conditions Studied
Interventions
- DEVICE Deep Brain Stimulation
- DRUG Anti-Parkinson medication
Study Locations (1)
Massachusetts
- Clinical Research Center BIDMC - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2026-06-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02994719
The ClinicalTrials.gov registry entry for NCT02994719 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (81% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which Deep Brain Stimulation is the first listed.
NCT02994719 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02994719 about?
NCT02994719 is a clinical study titled "Gait Analysis in Neurological Disease". The purpose of this study is to investigate whether speed-dependent measures of gait can be identified in patients with neurological conditions that affect gait, particularly in subjects with parkinsonian disorders.
What is the current status of trial NCT02994719?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2016-03-01. Estimated completion is 2026-06-20.
What conditions does trial NCT02994719 study?
This clinical trial studies the following conditions: Parkinson's Disease, Huntington Disease, Multiple System Atrophy, Progressive Supranuclear Palsy, Corticobasal Degeneration.
What interventions are being tested in trial NCT02994719?
The interventions under investigation include: Deep Brain Stimulation (DEVICE), Anti-Parkinson medication (DRUG).
Who is sponsoring clinical trial NCT02994719?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02994719 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.